510(k) Report

FDA applicant

Genadyne Biotechnologies, Inc.

Hicksville, NY21 decisions2008–20260 recalls

FDA records 21 decisions for Genadyne Biotechnologies, Inc. (Hicksville, NY) from 2008 to 2026: 21 510(k) clearances. Most are in product codes OMP (Negative Pressure Wound Therapy Powered…) and HGX (Pump, Breast, Powered). Since 2016 its 510(k)s took a median of 325 days from receipt to decision, against 198 for FDA’s reviews in the same codes and years. Its devices cite 24 predicates, 12 of them its own earlier devices. No recall is linked to its devices.

FDA’s records also spell it “Genadyne Biotechnologies”.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, general and plastic surgery panel, where it files most

How often FDA has decided Genadyne Biotechnologies, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

2in 2024

2008: 22009: 12010: 12011: 12012: 12014: 12015: 42017: 12018: 12019: 12020: 12022: 22023: 12024: 22026 (partial year): 1
2008high 4 (2015) · low 0 (2013)2026

2026 so far, outlined.

Recalls per year

No recall linked to its devices since 2008.

FIG. 1 — Genadyne Biotechnologies, Inc. by year, 2008–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Genadyne Biotechnologies, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report